Skip to main content
main-content
Top

20-11-2017 | Cetuximab | Article

Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study

Herbst RS et al. Lancet Oncol 2017; 19(1): 101–114. doi:10.1016/S1470-2045(17)30694-0

Please log in to get access to this content

Related topics